CFGS
DGX icon

Concourse Financial Group Securities’s Quest Diagnostics DGX Stock Holding History

Concourse Financial Group Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,337
Closed -$204K – 501
2024
Q4 		$204K Buy
1,337
+95
+8% +$14.8K 0.01% 718
2024
Q3 		$193K Sell
1,242
-64
-5% -$9.56K 0.01% 725
2024
Q2 		$179K Sell
1,306
-15
-1% -$2.05K 0.01% 723
2024
Q1 		$176K Sell
1,321
-200
-13% -$25.9K 0.01% 719
2023
Q4 		$210K Sell
1,521
-4
-0.3% -$526 0.02% 641
2023
Q3 		$186K Buy
1,525
+49
+3% +$6.53K 0.01% 640
2023
Q2 		$208K Buy
1,476
+9
+0.6% +$1.24K 0.02% 632
2023
Q1 		$208K Buy
1,467
+12
+0.8% +$1.72K 0.02% 634
2022
Q4 		$228K Sell
1,455
-29
-2% -$4.17K 0.02% 576
2022
Q3 		$182K Sell
1,484
-40
-3% -$5.27K 0.02% 559
2022
Q2 		$203K Buy
1,524
+125
+9% +$17K 0.02% 599
2022
Q1 		$192K Sell
1,399
-88
-6% -$12.3K 0.01% 645
2021
Q4 		$257K Sell
1,487
-15
-1% -$2.28K 0.01% 646
2021
Q3 		$218K Buy
1,502
+203
+16% +$29.7K 0.01% 691
2021
Q2 		$171K Sell
1,299
-591
-31% -$77.4K 0.01% 763
2021
Q1 		$243K Sell
1,890
-446
-19% -$55K 0.02% 616
2020
Q4 		$278K Sell
2,336
-488
-17% -$59.5K 0.02% 522
2020
Q3 		$323K Buy
2,824
+300
+12% +$35.4K 0.03% 426
2020
Q2 		$288K Buy
2,524
+684
+37% +$72.5K 0.03% 424
2020
Q1 		$148K Buy
1,840
+191
+12% +$19.8K 0.02% 540
2019
Q4 		$176K Buy
1,649
+249
+18% +$26K 0.02% 532
2019
Q3 		$150K Sell
1,400
-45
-3% -$4.62K 0.04% 346
2019
Q2 		$147K Buy
1,445
+64
+5% +$6.15K 0.01% 560
2019
Q1 		$124K Sell
1,381
-30
-2% -$2.6K 0.01% 618
2018
Q4 		$117K Buy
1,411
+353
+33% +$33.1K 0.01% 595
2018
Q3 		$114K Buy
+1,058
New +$116K 0.03% 397

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Concourse Financial Group Securities's DGX Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Quest Diagnostics (DGX) in Q1 2025, closing a stake of 1,337 shares — an estimated $204K sold.

Concourse Financial Group Securities first reported a position in DGX in Q3 2018 and held it in 26 quarters. The position peaked at $323K in Q3 2020. 968 funds tracked by Wall St. Rank hold DGX as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Quest Diagnostics position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1,337 Quest Diagnostics shares in Q1 2025, an estimated $204K.
  • Concourse Financial Group Securities first reported a position in Quest Diagnostics in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Quest Diagnostics position peaked at $323K in Q3 2020.
  • 968 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.